R-CHOP regimen: Difference between revisions

	WikiDoc Resources for R-CHOP regimen
Articles
Most recent articles on R-CHOP regimen Most cited articles on R-CHOP regimen Review articles on R-CHOP regimen Articles on R-CHOP regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on R-CHOP regimen Images of R-CHOP regimen Photos of R-CHOP regimen Podcasts & MP3s on R-CHOP regimen Videos on R-CHOP regimen
Evidence Based Medicine
Cochrane Collaboration on R-CHOP regimen Bandolier on R-CHOP regimen TRIP on R-CHOP regimen
Clinical Trials
Ongoing Trials on R-CHOP regimen at Clinical Trials.gov Trial results on R-CHOP regimen Clinical Trials on R-CHOP regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on R-CHOP regimen NICE Guidance on R-CHOP regimen NHS PRODIGY Guidance FDA on R-CHOP regimen CDC on R-CHOP regimen
Books
Books on R-CHOP regimen
News
R-CHOP regimen in the news Be alerted to news on R-CHOP regimen News trends on R-CHOP regimen
Commentary
Blogs on R-CHOP regimen
Definitions
Definitions of R-CHOP regimen
Patient Resources / Community
Patient resources on R-CHOP regimen Discussion groups on R-CHOP regimen Patient Handouts on R-CHOP regimen Directions to Hospitals Treating R-CHOP regimen Risk calculators and risk factors for R-CHOP regimen
Healthcare Provider Resources
Symptoms of R-CHOP regimen Causes & Risk Factors for R-CHOP regimen Diagnostic studies for R-CHOP regimen Treatment of R-CHOP regimen
Continuing Medical Education (CME)
CME Programs on R-CHOP regimen
International
R-CHOP regimen en Espanol R-CHOP regimen en Francais
Business
R-CHOP regimen in the Marketplace Patents on R-CHOP regimen
Experimental / Informatics
List of terms related to R-CHOP regimen

VisualWikitext

Latest revision as of 13:45, 11 March 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone regimen

Overview

R-CHOP regimen refers to an immunochemotherapy regimen consisting of rituximab, cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine (Oncovin) and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma.^[1]^[2]

Regimen

RRituximab

CCyclophosphamide

HDoxorubicin (Hydroxydaunomycin)

OVincristine (Oncovin)

PPrednisone

Indications

References

↑ "NCI Thesaurus".
↑ "R-CHOP - National Cancer Institute".
↑ Coiffier, Bertrand (2002-01-24). "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma". The New England Journal of Medicine. 346 (4): 235–242. doi:10.1056/NEJMoa011795. ISSN 1533-4406. PMID 11807147. Unknown parameter |coauthors= ignored (help)
↑ Kluin-Nelemans, H. C. (2012-08-09). "Treatment of older patients with mantle-cell lymphoma". The New England Journal of Medicine. 367 (6): 520–531. doi:10.1056/NEJMoa1200920. ISSN 1533-4406. PMID 22873532. Unknown parameter |coauthors= ignored (help)

[1] "NCI Thesaurus".

[2] "R-CHOP - National Cancer Institute".

[3] Coiffier, Bertrand (2002-01-24). "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma". The New England Journal of Medicine. 346 (4): 235–242. doi:10.1056/NEJMoa011795. ISSN 1533-4406. PMID 11807147. Unknown parameter |coauthors= ignored (help)

[4] Kluin-Nelemans, H. C. (2012-08-09). "Treatment of older patients with mantle-cell lymphoma". The New England Journal of Medicine. 367 (6): 520–531. doi:10.1056/NEJMoa1200920. ISSN 1533-4406. PMID 22873532. Unknown parameter |coauthors= ignored (help)

[1]

[2]

[3]

[4]

@@ Line 9: / Line 9: @@
 ==Regimen==
-[[Rituximab|{{button|R – Rituximab}}]]
+{{chemo|R|Rituximab}}
-[[Cyclophosphamide|{{button|C – Cyclophosphamide}}]]
+{{chemo|C|Cyclophosphamide}}
-[[Doxorubicin|{{button|H – Doxorubicin (Hydroxydaunomycin)}}]]
+{{chemo|H|Doxorubicin (Hydroxydaunomycin)}}
-[[Vincristine|{{button|O – Vincristine (Oncovin)}}]]
+{{chemo|O|Vincristine (Oncovin)}}
-[[Prednisone|{{button|P – Prednisone}}]]
+{{chemo|P|Prednisone}}
 ==Indications==
 * [[Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma, untreated]]<ref>{{Cite journal | doi = 10.1056/NEJMoa011795 | issn = 1533-4406 | volume = 346 | issue = 4 | pages = 235–242 | last = Coiffier | first = Bertrand | coauthors = Eric Lepage, Josette Briere, Raoul Herbrecht, Hervé Tilly, Reda Bouabdallah, Pierre Morel, Eric Van Den Neste, Gilles Salles, Philippe Gaulard, Felix Reyes, Pierre Lederlin, Christian Gisselbrecht | title = CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma | journal = The New England Journal of Medicine | date = 2002-01-24 | pmid = 11807147 }}</ref>
+* [[Mantle cell lymphoma]]<ref>{{Cite journal | doi = 10.1056/NEJMoa1200920 | issn = 1533-4406 | volume = 367 | issue = 6 | pages = 520–531 | last = Kluin-Nelemans | first = H. C. | coauthors = E. Hoster, O. Hermine, J. Walewski, M. Trneny, C. H. Geisler, S. Stilgenbauer, C. Thieblemont, U. Vehling-Kaiser, J. K. Doorduijn, B. Coiffier, R. Forstpointner, H. Tilly, L. Kanz, P. Feugier, M. Szymczyk, M. Hallek, S. Kremers, G. Lepeu, L. Sanhes, J. M. Zijlstra, R. Bouabdallah, P. J. Lugtenburg, M. Macro, M. Pfreundschuh, V. Procházka, F. Di Raimondo, V. Ribrag, M. Uppenkamp, M. André, W. Klapper, W. Hiddemann, M. Unterhalt, M. H. Dreyling | title = Treatment of older patients with mantle-cell lymphoma | journal = The New England Journal of Medicine | date = 2012-08-09 | pmid = 22873532 }}</ref>
-==See also==
-* [[ACVBP-R regimen]]
-* [[CDOP regimen]]
-* [[CHOEP regimen]]
-* [[CHOP regimen]]
-* [[CHOP Intensified regimen]]
-* [[CHOP Modified regimen]]
-* [[CNOP regimen]]
-* [[DA-EPOCH regimen]]
-* [[DA-R-EPOCH regimen]]
-* [[LR-CHOP-21 regimen]]
-* [[m-BACOD regimen]]
-* [[MACOP-B regimen]]
-* [[MCOP regimen]]
-* [[ProMACE-CytaBOM regimen]]
-* [[ProMACE-MOPP regimen]]
-* [[R-CDOP regimen]]
-* [[R-CEOP regimen]]
-* [[R-CHMP regimen]]
-* [[R-CHOEP-14 regimen]]
-* [[R-CHOP Intensified regimen]]
-* [[R-CVP regimen]]
-* [[R-GCVP regimen]]
-* [[R-HCVAD/R-MA regimen]]
-* [[R-miniCEOP regimen]]
-* [[R-miniCHOP regimen]]
-* [[R2CHOP regimen]]
-* [[VR-CHOP regimen]]
 ==References==

R-CHOP regimen: Difference between revisions

Latest revision as of 13:45, 11 March 2015

Overview

Regimen

Indications

References

Navigation menu